Growth Metrics

GoodRx Holdings (GDRX) Cash from Financing Activities (2019 - 2026)

GoodRx Holdings recorded quarterly Cash from Financing Activities of -$16.3 million in Q1 2026, down 27.11% quarter-over-quarter from -$12.8 million in Q4 2025, and up 84.46% year-over-year from -$8.8 million in Q1 2025.

GoodRx Holdings' Cash from Financing Activities history runs 8 years deep, the most recent figure standing at -$16.3 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 84.46% year-over-year to -$16.3 million; the TTM figure through Mar 2026 stood at -$145.9 million (up 48.17% YoY), while the FY2025 annual figure was -$234.5 million, up 30.53% from the prior year.
  • Cash from Financing Activities came in at -$16.3 million for Q1 2026 at GoodRx Holdings, down from -$12.8 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of -$864000.0 in Q2 2024 to a low of -$172.1 million in Q3 2024.
  • A 5-year average of -$51.5 million and a median of -$16.3 million in 2026 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities surged 97.19% in 2024 and sank 5794.44% in 2025, its largest moves.
  • GoodRx Holdings' Cash from Financing Activities stood at -$4.8 million in 2022, then slumped by 2524.43% to -$125.6 million in 2023, then soared by 97.19% to -$3.5 million in 2024, then sank by 263.37% to -$12.8 million in 2025, then retreated by 27.11% to -$16.3 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$16.3 million, -$12.8 million, and -$65.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -178.05 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn -70.02 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -137.18 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -112.85 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -93.16 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 13.46 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -8.42 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -10.67 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 2.39 Mn
10 GoodRx Holdings 1.05 Bn 814.83 Mn 112.95 Mn -16.30 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -16.30 Mn
Mar 31, 2026 -16.30 Mn
Dec 31, 2025 -12.83 Mn
Dec 31, 2025 -12.83 Mn
Sep 30, 2025 -65.81 Mn
Sep 30, 2025 -65.81 Mn
Jun 30, 2025 -50.93 Mn
Jun 30, 2025 -50.93 Mn
Mar 31, 2025 -104.90 Mn
Mar 31, 2025 -104.90 Mn
Dec 31, 2024 -3.53 Mn
Dec 31, 2024 -3.53 Mn
Sep 30, 2024 -172.13 Mn
Sep 30, 2024 -172.13 Mn
Jun 30, 2024 -864,000.00
Jun 30, 2024 -864,000.00
Mar 31, 2024 -160.97 Mn
Mar 31, 2024 -160.97 Mn
Dec 31, 2023 -125.61 Mn
Dec 31, 2023 -125.61 Mn
Sep 30, 2023 -13.71 Mn
Sep 30, 2023 -13.71 Mn
Jun 30, 2023 -13.99 Mn
Jun 30, 2023 -13.99 Mn
Mar 31, 2023 -14.09 Mn
Mar 31, 2023 -14.09 Mn
Dec 31, 2022 -4.79 Mn
Dec 31, 2022 -4.79 Mn
Sep 30, 2022 -21.71 Mn
Sep 30, 2022 -21.71 Mn
Jun 30, 2022 -2.33 Mn
Jun 30, 2022 -2.33 Mn
Mar 31, 2022 -91.40 Mn
Mar 31, 2022 -91.40 Mn
Dec 31, 2021 -11.47 Mn
Dec 31, 2021 -11.47 Mn
Sep 30, 2021 -4.18 Mn
Sep 30, 2021 -4.18 Mn
Jun 30, 2021 -865,000.00
Jun 30, 2021 -865,000.00
Mar 31, 2021 -14.02 Mn
Mar 31, 2021 -14.02 Mn
Dec 31, 2020 -111.37 Mn
Dec 31, 2020 -111.37 Mn
Sep 30, 2020 992.12 Mn
Sep 30, 2020 992.12 Mn
Jun 30, 2020 -2.53 Mn
Jun 30, 2020 -2.53 Mn
Mar 31, 2020 27.60 Mn
Mar 31, 2020 27.60 Mn
Dec 31, 2019 -48.38 Mn
Dec 31, 2019 -48.38 Mn